Fast L - Search Results

1

Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism.

Colvin GA, Berz D, Ramanathan M, Winer ES, Fast L, Elfenbein GJ, Quesenberry PJ. Colvin GA, et al. Among authors: fast l. Biol Blood Marrow Transplant. 2009 Apr;15(4):421-31. doi: 10.1016/j.bbmt.2008.12.503. Biol Blood Marrow Transplant. 2009. PMID: 19285629 Free article. Clinical Trial.

2

Cellular immunotherapy for refractory hematological malignancies.

Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ. Reagan JL, et al. Among authors: fast ld. J Transl Med. 2013 Jun 19;11:150. doi: 10.1186/1479-5876-11-150. J Transl Med. 2013. PMID: 23782682 Free PMC article. Clinical Trial.

3

Nonengraftment haploidentical cellular therapy for hematologic malignancies.

Reagan JL, Fast LD, Winer ES, Safran H, Butera JN, Quesenberry PJ. Reagan JL, et al. Among authors: fast ld. Adv Hematol. 2012;2012:784213. doi: 10.1155/2012/784213. Epub 2012 Jan 18. Adv Hematol. 2012. PMID: 22312367 Free PMC article.

4

Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia.

Reagan JL, Fast LD, Nevola M, Mantripragada K, Mulder A, Claas FH, Rosati K, Schumacher A, Safran H, Young CT, Quesenberry MI, Winer ES, Butera JN, Quesenberry PJ. Reagan JL, et al. Among authors: fast ld. Blood Cancer J. 2015 Dec 4;5(12):e371. doi: 10.1038/bcj.2015.100. Blood Cancer J. 2015. PMID: 26636286 Free PMC article. Clinical Trial. No abstract available.

5

Advances in cellular therapy for the treatment of leukemia.

Mantripragada K, Reagan JL, Quesenberry PJ, Fast LD. Mantripragada K, et al. Among authors: fast ld. Discov Med. 2014 Jan;17(91):15-24. Discov Med. 2014. PMID: 24411697 Free article. Review.

6

Extracellular vesicles in leukemia.

Pando A, Reagan JL, Quesenberry P, Fast LD. Pando A, et al. Among authors: fast ld. Leuk Res. 2018 Jan;64:52-60. doi: 10.1016/j.leukres.2017.11.011. Epub 2017 Nov 22. Leuk Res. 2018. PMID: 29190514 Review.

7

Immune responses to major histocompatibility complex homozygous lymphoid cells in murine F1 hybrid recipients: implications for transfusion-associated graft-versus-host disease.

Fast LD, Valeri CR, Crowley JP. Fast LD, et al. Blood. 1995 Oct 15;86(8):3090-6. Blood. 1995. PMID: 7579403 Free article.

8

Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice.

Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R. Fast LD, et al. Transfusion. 2006 Sep;46(9):1553-60. doi: 10.1111/j.1537-2995.2006.00939.x. Transfusion. 2006. PMID: 16965583

9

Recipient elimination of allogeneic lymphoid cells: donor CD4(+) cells are effective alloantigen-presenting cells.

Fast LD. Fast LD. Blood. 2000 Aug 1;96(3):1144-9. Blood. 2000. PMID: 10910935 Free article.

10

Identification of a single non-H-2 gene regulating graft-versus-host disease response.

Fast LD. Fast LD. J Immunol. 1990 Jun 1;144(11):4177-82. J Immunol. 1990. PMID: 2111342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters